Overview
Ketamine, a dissociative anesthetic originally developed in the 1960s, has transcended its initial role in surgical settings to become a critical therapeutic agent for severe depression and other mental health conditions. Its unique mechanism of action, primarily as an NMDA receptor antagonist, allows it to rapidly alleviate symptoms of treatment-resistant depression, suicidal ideation, and PTSD, often within hours of administration. While its anesthetic properties are well-established, particularly in emergency medicine due to its favorable hemodynamic profile and preserved respiratory function, its sub-anesthetic applications are rapidly expanding. Research continues to explore its efficacy across a spectrum of psychiatric disorders, alongside ongoing investigations into its neurobiological effects and long-term safety profiles. The controlled administration of ketamine, often within a therapeutic framework like [[ketamine-assisted-therapy|ketamine-assisted therapy]], is paramount for maximizing benefits while mitigating risks associated with its dissociative and potential for misuse.